Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net comprehensive loss for the period $ (511) $ (867) $ (2,575) $ (4,355)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation     11 20  
Changes in fair value related to warrants to lenders and investors     (1,658)  
Warrant issuance costs     223  
Inventories write-downs 14 35 39 132  
Interest expenses     (56)  
Exchange rate differences     (58) (365)  
Share-based compensation     259 298  
Financial income from short and long term bank deposit     (11) (78)  
Changes in operating assets and liabilities:          
Trade receivables     (1,164) 2,319  
Net change in operating lease assets and liabilities     12 25  
Inventories     115 (1,651)  
Prepaid expenses and other current assets     (140) 62  
Long term prepaid expenses     (100)  
Trade payables     (875) 411  
Deferred revenues     (23) (262)  
Other current liabilities     (350) (185)  
Other long-term liabilities     35 (30)  
Net cash used in operating activities     (4,781) (5,194)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Short term deposits     198 1,363  
Long term Restricted bank deposits     75  
Long term deposits     (2)  
Purchase of property and equipment     (1) (6)  
Net cash provided by investing activities     197 1,430  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from exercise of options     32 10  
Proceeds from issuance of common stocks, pre-funded warrants and warrants     [1] 3,500  
Proceeds from issuance common stock, net of offering costs     316  
Proceeds from credit lines with bank, net     927  
Proceeds from Warrant inducement agreement     5,248  
Underwriting discounts and commissions and other offering costs     (668) (291)  
Early repayment of long-term loan     (4,038)  
Repayment of long-term loan     (193) (583)  
Repurchase of common stock     (50)  
Net cash provided by financing activities     1,624 2,586  
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS     (14) (12)  
DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS     (2,974) (1,190)  
BALANCE OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD     5,515 4,279 $ 4,279
BALANCE OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT END OF THE PERIOD 2,541 3,089 2,541 3,089 5,515
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH:          
Cash and cash equivalents 2,241 682 2,241 682 620
Restricted cash equivalents, current 300 300 1,565
Restricted cash and cash equivalents, non-current 2,407 2,407  
Total cash, cash equivalents and restricted cash $ 2,541 $ 3,089 2,541 3,089 $ 5,515
SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid for interest     576 512  
SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:          
Issuance costs of common stock, pre-funded warrants and warrants     104  
Reclassification of warrants from liability to equity upon amendment to private placement agreement     314  
Issuance costs of the Warrant inducement agreement     2,651  
Warrant to lender     $ 61  
[1] Represents an amount less than $1 thousand.